Dissolution Method Troubleshooting: An Industry Perspective

IF 1 4区 医学 Q4 PHARMACOLOGY & PHARMACY Dissolution Technologies Pub Date : 2022-01-01 DOI:10.14227/dt290422p190
J. Mann, Andre Hermans, Nathan D. Contrella, B. Nickerson, Carrie A. Coutant, Christian Jede, S. Kao, D. Kou, Emmanuel Scheubel, Fredrik Winge, Johanna Milsmann, M. Mueller-Zsigmondy, N. Zaborenko
{"title":"Dissolution Method Troubleshooting: An Industry Perspective","authors":"J. Mann, Andre Hermans, Nathan D. Contrella, B. Nickerson, Carrie A. Coutant, Christian Jede, S. Kao, D. Kou, Emmanuel Scheubel, Fredrik Winge, Johanna Milsmann, M. Mueller-Zsigmondy, N. Zaborenko","doi":"10.14227/dt290422p190","DOIUrl":null,"url":null,"abstract":"Quality control dissolution testing represents a key product performance test for solid oral dosage forms and is the most likely QC test to result in laboratory investigations because of the relatively complex relationship between the dissolution performance, the drug product properties, and the systems necessary to measure the quality attribute. The Dissolution Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) has pooled our collective knowledge to outline some common ways that dissolution methods can fail. Examples and case studies are given to highlight errors related to equipment, method, materials, measurement, people, and the environment. Best practices for building method understanding and avoiding the exemplified issues are discussed. Case studies highlight the importance of buffer preparation, potential impact of contamination of the dissolution medium, additive-induced degradation, risks in the use of automation, differences between dissolution systems, and the effect of filter selection. Investing in analyst training programs, understanding the capabilities of your equipment portfolio, and using well-designed studies for robustness and ruggedness will reduce dissolution method investigations and improve compliance and productivity during the method lifecycle.","PeriodicalId":11380,"journal":{"name":"Dissolution Technologies","volume":"1 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dissolution Technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14227/dt290422p190","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Quality control dissolution testing represents a key product performance test for solid oral dosage forms and is the most likely QC test to result in laboratory investigations because of the relatively complex relationship between the dissolution performance, the drug product properties, and the systems necessary to measure the quality attribute. The Dissolution Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) has pooled our collective knowledge to outline some common ways that dissolution methods can fail. Examples and case studies are given to highlight errors related to equipment, method, materials, measurement, people, and the environment. Best practices for building method understanding and avoiding the exemplified issues are discussed. Case studies highlight the importance of buffer preparation, potential impact of contamination of the dissolution medium, additive-induced degradation, risks in the use of automation, differences between dissolution systems, and the effect of filter selection. Investing in analyst training programs, understanding the capabilities of your equipment portfolio, and using well-designed studies for robustness and ruggedness will reduce dissolution method investigations and improve compliance and productivity during the method lifecycle.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
溶解方法故障排除:行业视角
溶出度质量控制测试是固体口服剂型的关键产品性能测试,也是最有可能导致实验室调查的QC测试,因为溶出度性能、药品性质和测量质量属性所需的系统之间存在相对复杂的关系。国际药物开发创新和质量联盟(IQ)的溶出度工作组汇集了我们的集体知识,概述了溶出度方法可能失败的一些常见方式。举例和案例研究,以突出与设备,方法,材料,测量,人员和环境有关的错误。讨论了构建方法理解和避免示例问题的最佳实践。案例研究强调了缓冲液制备的重要性、溶解介质污染的潜在影响、添加剂引起的降解、自动化使用的风险、溶解系统之间的差异以及过滤器选择的影响。投资于分析人员培训计划,了解您的设备组合的能力,并使用设计良好的健壮性和坚固性研究,将减少溶解方法调查,并提高方法生命周期中的合规性和生产力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Dissolution Technologies
Dissolution Technologies 医学-药学
CiteScore
1.20
自引率
33.30%
发文量
14
审稿时长
3 months
期刊介绍: Dissolution Technologies is a peer reviewed quarterly publication reporting ongoing, useful information on dissolution testing of pharmaceuticals. It provides an international forum for dissolution analysts to receive and exchange information on various dissolution topics. Dissolution Technologies welcomes submissions related to dissolution, in vitro release, and disintegration testing. These topics should be the major focus of the article. Do not submit articles where the focus is formulation development with dissolution testing as one of many tests.
期刊最新文献
Steady-state burning plasma: a new stage in the development of magnetic confinement fusion energy. Investigating the Influence of HPMC K4M and Eudragit L 100-55 on Guanfacine-Loaded Extended-Release Tablets Questions and Answers February 2023 Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework Physicochemical Quality and In Vitro Bioequivalence of Amoxicillin Capsules Marketed in Burkina Faso, Africa
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1